You are here

Inotuzumab Ozogamicin - PF-05208773

Last updated on April 10, 2018

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0+
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details
Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT03127605
Pfizer
Available
Inotuzumab Ozogamicin - PF-05208773

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Inotuzumab Ozogamicin - PF-05208773
Not Provided

Information relating to requesting compassionate access for this investigational drug can be found at the following link:

http://www.pfizer.com/research/compassionate_use

Not Provided
Expanded Access
Individual Patients
Not Provided
Drug: Inotuzumab Ozogamicin
Other Name: PF-05208773
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Available

Inclusion Criteria:

Exclusion Criteria:

Not Provided
Child, Adult, Senior

Contact: Pfizer CAReS 1-800-718-1021 [email protected]
Not Provided
 
 
NCT03127605
B193
Pfizer
Pfizer
Not Provided
Not Provided
Pfizer
April 2017

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now